Phase i/ii study of docetaxel (DOC) and carboplatin (CBDCA) with concurrent radiotherapy in patients with stage III unresectable non-small cell lung cancer (NSCLC), preliminary results

Shingo Kato, Seiji Kosaihira, Tomoko Kazumoto et al.|European Journal of Cancer|2001

Cited by 0